<DOC>
	<DOC>NCT00712218</DOC>
	<brief_summary>To assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking. Secondary: progression-free survival, complications and quality of life; Exploratory: Role of number of resected lymph nodes for primary and secondary objectives</brief_summary>
	<brief_title>Lymphadenectomy In Ovarian Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Primary diagnosis of invasive epithelial ovarian cancer FIGO stage IIBIV (IV only if resectable metastasis in pleura, liver, spleen, and/or abdominal wall) Macroscopic complete resection Age: 18 75 years Patients who have given their signed and written informed consent Good performance status (ECOG 0/1) Non epithelial ovarian malignancies and borderline tumors Intraoperative clinically suspicious lymph nodes (bulky nodes) Secondary invasive neoplasms in the last 5 years (except synchronal endometrial carcinoma FIGO IA G1/2, non melanoma skin cancer, breast cancer T1 N0 M0 G1/2) or with any signs of relapse or activity. Recurrent ovarian cancer Prior chemotherapy for ovarian cancer or abdominal/pelvic radiotherapy Diseases of the lymph system (including lymph edema of unknown origin) Clinical relevant dysfunctions of blood clotting (including medicamentous conditioned reasons, e.g. ASS, if not stopped at least 7 days prior to surgery) Any significant medical reasons, age or performance status that will not allow to perform the study procedures (estimation of investigator) Prior retroperitoneal lymph node dissection (systematic or sampling) Pregnancy Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent Any reasons interfering with regular followup</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Ovarian cancer, FIGO stage IIB-IV</keyword>
</DOC>